US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 4.1500
  • -0.5700-12.08%
Trading Dec 13 13:09 ET
37.03MMarket Cap-3.81P/E (TTM)

About Marker Therapeutics Company

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Company Profile

SymbolMRKR
Company NameMarker Therapeutics
Listing DateNov 7, 2016
Founded1991
CEODr. Juan Vera, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address2450 Holcombe Boulevard,Suite BCM-A, MS: BCM251
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77021
Phone1-713-400-6400

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Juan Vera, M.D.
  • Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • 585.25K
  • N. David Eansor
  • Chairman of the Board
  • 124.04K
  • Steven A. Elms
  • Independent Director
  • 76.14K
  • John Wilson
  • Independent Director
  • 63.44K
  • Dr. Katharine Knobil, M.D.
  • Independent Director
  • 79.67K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.